Cephalexin For Suspension
Product Images NDC 50090-7091

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 50090-7091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 01)

Image (F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 01)
Chemical structure of cephalexin hydrate, showing the molecular arrangement including a beta-lactam ring, thiadiazole ring, and associated functional groups.*
FDA Label Image

Label Image (Lbl500907091)

Label Image (Lbl500907091)
Label for Cephalexin oral suspension, 250 mg per 5 mL, supplied by A-S Medication Solutions. The label indicates the product is a human prescription drug in liquid form for oral use. It includes storage instructions to keep the suspension at 68 to 77 degrees Fahrenheit and specifies a volume of 200 mL when mixed. The label also shows NDC 50090-7091 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.